baber/WOPTO huggingface dataset:
Patent JP-2000510830-A (JP)
Title: インダセン化合物の製造法
IPC: A61K31/351
Filed: 1997-05-06
Abstract: (57)【要約】
化合物(I)の製造法、およびこの方法に用いる新規な中間体。
Patent JP-2001514660-A (JP)
IPC: A61P11/06
Filed: 1998-03-10
Abstract: Compounds of formula (I) are antagonists of the actions of leukotrienes. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
Patent JP-2000510762-A (JP)
Title: 希薄気体流に入っているＮＯ▲下ｘ▼を減少させる方法及び装置
IPC: F01N3/28
Filed: 1997-03-28
Abstract: (57)【要約】
希薄気体流に入っているＮＯ x を減少させる方法に、上記気体流を収着材との密な組み合わせで酸化触媒が入っている触媒含有捕捉部材の中にＮＯ x の収着が起こる温度範囲内の温度で通すことを含める。上記気体流の中に燃焼性成分を導入してそれを上記捕捉部材の所で酸化させてその熱でＮＯ x を脱離させることを通して、その収着させたＮＯ x を定期的に取り除く。この導入する燃焼性成分の量を、上記気体流のバルク組成が希薄状態に維持されそして上記気体流のバルク温度が有効な希薄ＮＯ x 減少処理にとって高すぎる温度にまで上昇しないように制限する。その脱離したＮＯ x を減少させるに適切なＮＯ x 減少用触媒を用いる。収着（捕捉）期間および脱離期間を通常は上記気体流の温度に応答させて交互に存在させ、そしてこの方法を実施するための装置を提供する。
Patent JP-2001505666-A (JP)
Title: 探査方法及び無線航行装置を備える探査装置
IPC: G01S19/51
Filed: 1998-03-19
Abstract: (57)【要約】
探査機器（１）と、無線航行アンテナ（２）及び無線航行レシーバを備える無線航行装置とを備え、アンテナ及びレシーバの双方が探査装置に及び探査物（６）に着脱可能に接続可能である、探査システムが提供される。該物には、該物に向けるべき探査装置（１）に対する少なくとも１つの標的手段（７）が設けられる。着脱可能な制御盤手段（３）が無線航行装置及び探査装置（１）と随意に協働する。制御盤手段は、無線航行レシーバ及び探査装置の双方を作動させ得るようにしたプログラムシステムが設けられたコンピュータを備えている。
Patent JP-2002517168-A (JP)
Title: 超短時間作用性神経筋遮断薬としての置換イソキノリン類
IPC: C07D491/056
Filed: 1998-03-23
Abstract: (57)【要約】
緊急の挿管処置、通常の外科手術および術後環境中の骨格筋弛緩として有用な式（Ｉ）{式中：Ｘはハロゲンであり；ｈは１〜２であり；Ｙは水素またはメトキシであり；Ｚ 1 およびＺ 2 はメチルであり；Ｗ 1 およびＷ 2 は炭素であり；かつＡは薬学上許容されるアニオンである}で示される超短時間作用性神経筋遮断薬が開示される。
Patent JP-2002512729-A (JP)
Title: 金属複合体光増感剤および光起電力セル
IPC: H01G9/20
Filed: 1998-05-07
Abstract: (57)【要約】
式（Ｉａ）ＭＸ３Ｌ t または（ｌｂ）ＭＸＹＬ t （式中、Ｍはルテニウム、オスミウム、鉄、レニウム、およびテクネチウムから選ばれた遷移金属、好ましくはルテニウムまたはオスミウムであり；個々のＸは、独立に、ＮＣＳ - 、Ｃｌ - 、Ｂｒ - 、Ｉ - 、ＣＮ - 、ＮＣＯ - 、Ｈ 2 Ｏ、ＮＣＮ 2   - 、非置換またはビニル、第１級、第２級または第３級のアミン、ＯＨおよびＣ 1   〜30 アルキルから選ばれた少くとも１つの基により置換されたピリジンから選ばれ；好ましくはＮＣＳ - である共リガンドであり；Ｌ t は少なくとも１個のカルボン酸、リン酸、ヒドロキサミン酸またはキレート基を有するトリアゾール、ピリジン、チオフェン、イミダゾール、ピラゾール等のヘテロ環、またはキレート基を含む三座配位のリガンドである）光増感剤複合体。少くとも１つの二酸化チタン層が塗布された支持体上に堆積された電気的に伝導性の層を含む光起電力セルであって；それが前記二酸化チタン層に塗布された光増感剤として、上記で特定された式（Ｉａ）または（ｌｂ）の光増感剤複合体を含む光起電力セル。
Patent MD-20000205-A (MD)
Title: Special vodka
Inventor: TONCIUC VLADIMIR
IPC: C12G3/06
Filed: 2000-12-08
Abstract: The invention refers to the alcoholic beverage industry, namely to a composition for vodka.The given composition includes: aromatic garden sage alcohol, aromatic hyssop alcohol, sugar, citric acid and hydroalcoholic solution in the following component ratio, in L to 1000 dal of blending:
Patent MD-20010213-A (MD)
Title: Method for marking and authentificating an object
Inventor: PERRON MAURICE
IPC: G07D7/16
Filed: 2000-11-03
Abstract: The invention concerns a method for marking (A, B) and authentificating (C ) an object (10) comprising the combination of two different data (K, N) mutually linked by means of a given arbitrary correspondence and used for authentificating the object, at least one of the two data (K) being intrinsically undetectable by an observer, the scanning of the two data and the verification of their mutual correspondence being performed during authentification of the object. The method is characterized in that the two data are non-random and said undetectable information is materialized by means interacting with the structure of the object. Claims: 27Fig.: 3<IMAGE>
Patent NZ-200296-A (NZ)
Title: Livestock feed and growth promoting agent containing antibiotic 5057a and/or 5057b
Inventor: KUSAKABE Y
IPC: A23K20/195
Filed: 1982-04-14
Abstract: An efficiency-improving agent for a livestock or poultry feed or a preventive and treating agent for livestock or poultry coccidiosis which contains antibiotic 5057A and/or 5057B. The agent has a special feature of low toxicity. The antibiotics may be in the form of a physiologically acceptable salt such as sodium and potassium salts. The agent is used as a preparation such as powders, tablets, capsules, granules, and pills; however, usually it is used by directly incorporating it into feed or drinking water or by adding its dispersion in a diluent to feed or drinking water.
Patent NZ-201705-A (NZ)
Title: Recombinant dna method for production of hepatitis b surface antigen in yeast
Inventor: HITZEMAN R A
IPC: C12N15/81
Filed: 1982-08-25
Abstract: The hepatitis B surface antigen (HBsAG) for use in hepatitis vaccine is produced in particle form (like the natural product) by yeast transformed with a vector. The use of yeast has advantages over prokaryotic hosts, e.g. in yields. A preferred vector is plasmid pYeHBs. This includes: a promoter derived from the yeast PKG promoter region; a LEU2 gene allowing for selection in yeast; and the HBsAg gene. This last war derived from a plasmid containing the complete HBV gene inserted into the EcoRI site of pBH322.
Patent NZ-209130-A (NZ)
Title: Thermal energy storage compositions
Inventor: HAWE M
IPC: C09K5/06
Filed: 1984-08-07
Abstract: A thermal energy storage composition is formed of a thermal energy storage hydrate and a solid, water swellable, thermally conducting polymer by blending particles of the polymer with the thermal energy storage hydrate.
Patent NZ-213721-A (NZ)
Title: Separating fatty acids by adsorption
Inventor: CLEARY M T
IPC: C07C51/47
Filed: 1985-10-07
Abstract: Saturated fatty acids differing in chain length by at least two carbon atoms can be separated by contacting a feed mixture containing the acids at adsorption conditions with an adsorbent comprising a crystalline silica having a silica to alumina mole ratio of at least 12:1, thereby selectively adsorbing the longer-chain saturated fatty acid. The remainder of the feed mixture is then removed from the adsorbent, and the selectively adsorbed acid recovered from the adsorbent by desorption at desorption conditions with a desorbent liquid soluble in the feed mixture and having a polarity index of at least 3.5.
Patent NZ-220722-A (NZ)
Title: Sustained release solid dosage forms containing polymer and ionic particulate material
Inventor: SELLASSIE ISSAC GHEBRE
IPC: A61K9/18
Filed: 1987-06-16
Abstract: Sustained release solid dosage forms--i.e., tablets pellets, granules, and powders--can be made using a combination of polymeric and ionic particulate materials to modify release profiles, permeability and processability.
Patent NZ-228478-A (NZ)
Title: Arylhydrazones and pharmaceutical compositions thereof
Inventor: STANEK JAROSLAV CARAVATTI GIOR
IPC: C07C337/06
Filed: 1989-03-23
Abstract: Compounds of formula I   <IMAGE> (I)  wherein A, X1, X2, X3, X4, Y, Z and R1 to R6 have the meanings given in the description, have valuable pharmaceutical properties and are effective especially against tumors. They are prepared in a manner known per se.
Patent NZ-234462-A (NZ)
Title: Liquid/liquid contacting with column having vibrating tongues in discs
Inventor: TAKACS ISTVAN
IPC: B01D11/04
Filed: 1990-07-11
Abstract: PCT No. PCT/HU90/00048 Sec. 371 Date Mar. 18, 1991 Sec. 102(e) Date Mar. 18, 1991 PCT Filed Jul. 18, 1990 PCT Pub. No. WO91/01170 PCT Pub. Date Feb. 7, 1991.The apparatus has a column (1) of closed interior. Pipe (7b) leading into its upper part to admit liquid of higher density, and pipe (7a) leading into the lower part to admit liquid of lower density. Pipes (8, 10) emerge from the lower part to discharge liquid of higher density, and from its upper part to discharge liquid of lower density. Level control and propelling force adjusting mechanism (9) is connected with the pipe discharging liquid of higher density. Dispersing-mixing elements surrounding cells are beneath and above each other in the column (1). Pulsator (4) is connected with the lower part of column (1). The dispersing-mixing elements are formed by discs (5) having elastic tongues (13a) in the plane of discs capable for vibration and to move out of the disc's plane during vibration, and gap (14) runs along the periphery of the tongues (13a).
Patent NZ-259790-A (NZ)
Title: Reducing cholesterol levels by combined use of a beta-lactam cholesterol absorption inhibitor with a cholesterol biosynthesis inhibitor (eg lovastatin)
Inventor: DAVIS HARRY R
IPC: A61K45/06
Filed: 1993-12-21
Abstract: PCT No. PCT/US93/12291 Sec. 371 Date Jun. 20, 1995 Sec. 102(e) Date Jun. 20, 1995 PCT Filed Dec. 21, 1993 PCT Pub. No. WO94/14433 PCT Pub. Date Jul. 7, 1994Methods of reducing plasma cholesterol levels and treating or preventing atherosclerosis comprising administering an effective amount of a combination of a cholesterol biosynthesis inhibitor and a  beta -lactam cholesterol absorption inhibitor, as well as pharmaceutical compositions and kits useful in those methods, are disclosed.
Patent NZ-261598-A (NZ)
Title: Antihelminth vaccines and their use
Inventor: ROLPH TIMOTHY PETER
IPC: A61K39/00
Filed: 1994-02-23
Abstract: The invention provides a use of a helminth hidden antigen, or antigenic fragments, precursors and functionally-equivalent derivatives or variants thereof having immunogenic activity against one or more helminth parasites, in the manufacture of a vaccine composition for administration to an animal at least once prior to and/or during a period of loss or warning of natural immunity to gastro-intestinal helminth parasites, whereby to stimulate protective immunity against said helminth parasites during the period of compromised natural immunity. The invention has particular utility in the control of the periparturient rise of the helminth nematode Haemonchus in sheep, and of type II ostertagiasis.
Patent NZ-282458-A (NZ)
Title: Production of chemically stable electrochemical cell by halogenation of polymeric cell structure
Inventor: COOLEY GRAHAM EDWARD
IPC: H01M50/124
Filed: 1995-03-24
Abstract: PCT No. PCT/GB95/00667 Sec. 371 Date Dec. 3, 1996 Sec. 102(e) Date Dec. 3, 1996 PCT Filed Mar. 24, 1995 PCT Pub. No. WO95/27751 PCT Pub. Date Oct. 19, 1995A method for the fabrication of an electrochemical cell which has long term chemical stability to anolyte and catholyte solutions at pH's of less than 2 and above 12, which method comprises the steps of: i) thermally processing a polymeric material which exhibits a glass transition to form the cell structure or components of the cell structure, and ii) subjecting the surfaces of the cell structure of components of the cell structure, which in use, will be in contact with the anolyte and catholyte solutions, to a post halogenation process, whereby the polymeric material forming the said surfaces undergoes halogen substitution to form a chemically stable halogen modified polymeric material.
Patent NZ-318392-A (NZ)
Title: Concrete is coloured using an aqueous polymer with pigment dispersed therein for longevity
Inventor: DRECHSLER ANDREAS
IPC: C04B111/82
Filed: 1996-09-04
Abstract: A method for producing colored concrete bodies, particularly colored concrete roof tiles, whereby pigment is added to the unprocessed concrete mix. In order to provide the production of permanently colored concrete bodies with reasonably priced pigments which are stable in outdoor exposure and are resistant to light, particularly UV, alkalis and heat. A cement compatible aqueous polymer dispersion in which organic pigment is dispersed is added to the unprocessed concrete mix. Suitable cement compatible polymer dispersions are aqueous polymer dispersions based on styrene and/or pure acrylate. Phthalocyanine and quinacridone pigments are particularly suitable as organic pigments.
Patent NZ-331071-A (NZ)
Title: Placing fibres on substrate for microscopic examination using electric field to align fibres
Inventor: CHUDLEIGH PETER W
IPC: D06H/
Filed: 1998-07-23
Abstract: Specimens for analysis, such as fibres 1 are dropped on to moving substrate 5 from hopper 2.  An electric field, perpendicular to the substrate, is produced by applying a voltage to electrodes 4 and 6. Electrode 4 is formed by a mesh formed in the hopper outlet.  The effect of the electric field is to cause the fibres to stand on end. As the substrate moves, the fibres are caused to lay flat by the effect of a second electric field parallel to the substrate, and parallel to the direction of movement of the substrate.  This second electric field is formed between electrode 6 and electrode 7.  This technique is stated to be useful for preparing fibre snippets for image analysis.
Patent NZ-332522-A (NZ)
Title: composition and method for controlling domestic insect pests containing a biphenyl substituted amino carbonyl benzamide derivative
Inventor: DYBAS JANE A
IPC: A01N25/00
Filed: 1997-05-17
Abstract: A method of controlling domestic insect pests which comprises applying to the site where control is sought an insecticidally effective amount of a compound of the formula above is claimed wherein: X and Y are both F or X is Cl and Y is H and Z is F, Cl, Br, alkyl, alkoxy, haloalkyl or haloalkoxy.
Patent NZ-335245-A (NZ)
Title: Grinding wheel hub for longer wheel life having recessed central portion of disc captured between lips of hub and epoxy applied between disc and hub
Inventor: TIMM F GUY
IPC: B24D5/12
Filed: 1997-11-25
Abstract: A wheel hub is provided for use in combination with conventional depressed center grinding wheels. The hub includes a generally cylindrical aperture bushing. A disc shaped flange extends radially from a medial portion of the bushing and terminates at a peripheral lip. The bushing is adapted to extend through a central bore of the wheel so that the lip engages the backing face of the wheel proximate an outermost circumference of the depressed center. A grinding face end of the bushing is "flangeable" radially outward to engage the front grinding face of the wheel and mechanically capture the wheel between the grinding face end and the flange. The flange, lip and backing face form a cavity into which epoxy resin is placed to chemically bond the hub to the wheel. The combination of mechanical fastening and chemical bonding adequately secures the hub to the wheel, nominally without requiring the flange to extend over the stub. It is stated that this assembly advantageously enables the wheel to be ground nominally to the stub, to provide improved wheel utilization.
Patent NZ-336892-A (NZ)
Title: Enhancement of growth in plants by applying a peptide or protein which elicits a hypersensitive response
Inventor: QIU DEWEN
IPC: A01N63/20
Filed: 1998-01-27
Abstract: A method of enhancing the growth of plants.  It involves applying a hypersensitive response elicitor polypeptide or protein in a non-infectious form to a plant or plant seed under conditions effective to enhance growth of the plant or plants produced from the plant seed.  Alternatively, transgenic plants or transgenic plant seeds transformed with a DNA molecule encoding a hypersensitive response elicitor polypeptide or protein can be provided and the transgenic plants or plants resulting from the transgenic plant seeds are grown under conditions effective to enhance plant growth.
Patent NZ-502883-A (NZ)
Title: Amplification directional characteristic for deaf aid set established by electronic filtering in accordance with acoustic reception delay at twin transducers
Inventor: MAISANO JOSEPH
IPC: H04R3/00
Filed: 1998-06-08
Abstract: A predetermined characteristic of amplification in dependency of the direction (q) from which acoustical signals are received at two spaced-apart acoustical/electrical transducers (1, 2) is formed in that repetitively a mutual delay signal (A10) is determined from the output signals of the transducers and according to the reception delay at the transducers, one (S1) of the output signals is filtered, thereby the filtering transfer characteristic is controlled in dependency of the mutual delay signal (A12). The output signal of the filtering (14) is exploited as electrical reception signal (Sr).
Patent NZ-507572-A (NZ)
Title: Retractor for vehicles
Inventor: PARK SANG-HEE
IPC: B60R22/405
Filed: 1999-05-07
Abstract: A retractor for vehicles.  A mechanism cover (4) and a spring cover (11) are assembled through a spool (3) and an inertia disc (6) and a sensor spring (7) are mounted in a frame (1).  The retractor prevents the loss phenomenon of binding function resulting from tip to tip phenomenon (paging phenomenon) with a frame gear when a spool is rotated by using an oval pivot point and varying each division of a tooth form in the frame.  Formation of a two-stepped tooth form in the spool enables operation of a vehicle sensing element without separate rachet parts.  Attaching the vehicle sensing element and a webbing sensing element to each of a mechanism cover and a spring cover reduces the number of parts and the size of the product while improving the binding power.
Patent NZ-509723-A (NZ)
Title: Enovin, a neurotrophic growth factor, protein, DNA molecule and uses in the manufacture of medicaments
Inventor: MEERT THEO FRANS
IPC: A61K45/00
Filed: 1999-07-14
Abstract: An isolated nucleic acid molecule encodes a neurotrophic growth factor designated enovin and has the amino acid sequence shown in Figure 1 or encodes a functional equivalent, derivative or bioprecursor of the growth factor. Also described growth factor, expression vectors, host cells, antisense molecules capable of hybridizing to the nucleic acid molecule, pharmaceutical compositions and antibodies. The antisense molecule, nucleic acid and growth factor can be used in the manufacture of a medicament for treating or preventing neural disorders selected from Parkinson's disease, Alzheimer's disease, neuronal disorders associated with expanded polyglutamine sequences such as Huntingdons disease, peripheral neuropathy, acute brain injury, nervous system tumours, multiple sclerosis, amyotrophic lateral sclerosis, peripheral nerve trauma, injury exposure to neurotoxins, multiple endocrine neoplasia, familial Hirschsprung disease, Prion associated diseases, Creutzfeld-Jacob disease, stroke, pain syndromes with a substantially peripheral or central neurogenic component, rheumatic/inflammatory diseases as well as conductance disturbances. The nucleic acid molecule and growth factor are also useful in treating gastrointestinal conditions mediated by hampered or impaired gastrointestinal transit, such as gastrooesophageal reflux, dyspepsia, gastroparesis, post operative ileus and intestinal pseudoobstruction, decreased peristalsis of the small or large intestine and/or delayed gastric emptying, constipation, intestinal atony, post-operative intestinal atony, irritable bowel syndrome(IBS), drug induced delayed transit, emesis and cytotoxic drug and radiation induced emesis, and for treating gastrointestinal disorders or conditions mediated by increased peristaltic intestinal movement, such as diarrhoea, including secretory diarrhoea, bacterial induced diarrhoea, choleic diarrhoea, travellers diarrhoea, and psychogenic diarrhoea, Crohns disease, spastic colon, irritable bowel syndrome (IBS) diarrheapredominant irritable bowel syndrome, bowel hypersensitivity and the reduction of pain associated with gastrointestinal hypersensitivity. Methods of identifying agonists or antagonists of a human neurotrophic growth factor are also described.
Patent NZ-515119-A (NZ)
Title: Prucalopride oral solution
Inventor: DE PROOST EDDY ANDRE JOSEE
IPC: A61P1/14
Filed: 2000-04-20
Abstract: An oral aqueous solution having a pH ranging from 2 to 5 and comprising as active ingredient 4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-pyridinyl]-7-benzofuran-carboxamide (prucalopride) and further containing benzoic acid.
Patent NZ-522942-A (NZ)
Title: A method of constructing a rail track in which a concrete slab is produced between concrete walls and rail track anchor memebers are inserted into the track slab
Inventor: SAYADI MARC
IPC: E01B37/00
Filed: 2002-12-03
Abstract: A method of constructing a rail track in which a concrete track slab (1) is produced and rail track anchor members (3) are inserted in said track slab (1) by an inserter system (20) mobile along the route of the rail track, which includes the following steps: a) using a machine for continuously pouring concrete to produce two concrete walls (2) laterally delimiting the edges of the track slab (1) to be poured; b) having allowed the concrete walls (2) to solidify, pouring the concrete track slab (1) between said walls (2) ; and c) using the inserter system (20) to insert anchor members (3) in the freshly poured track slab (1).
Patent NZ-527660-A (NZ)
Title: System for providing services and virtual programming interface
Inventor: FALKENTHROS HENRIK BO
IPC: G06F9/44
Filed: 2001-01-26
Abstract: A system for providing customer requested services relating to security, monitoring and/or data acquisition in relation to a data processing device and/or a data network (Target 1-Target k) of a customer, wherein: one or more of a plurality of tests are selected to be executed in relation to the data processing device and/or a data network (Target 1-Target k); the selection (201; 202; 203; 210) of one or more tests are executed from a server (TSMADARS server) which is connectable to the data processing devices and/or data network (Target 1-Target k) via a communication network (140), and wherein data representing results of the selection of tests may be accessed by the customer via a communication network and/or transmitted to the customer.
Patent NZ-529106-A (NZ)
Title: Nucleic acid vaccines for prevention of flavivirus infection
Inventor: CHANG GWONG-JEN
IPC: C12N15/09
Filed: 2002-04-04
Abstract: An isolated nucleic acid comprising a transcriptional unit encoding a signal sequence of a structural protein of a first flavivirus, such as a Japanese encephalitis virus, and an immunogenic flavivirus antigen of a second flavivirus, such as yellow fever virus, dengue serotype 1virus, dengue serotype 2 virus, dengue serotype 3 virus, dengue serotype 4 virus, Japanese encephalitis virus, Powassan virus or West Nile virus, wherein the transcriptional unit directs the synthesis of the antigen; isolated cells, vectors and compositions comprising the nucleic acid; the use of the nucleic acid, vector or composition for the manufacture of a medicament for immunizing a subject against infection by a flavivirus; an antigen produced from the nucleic acid; and method for detecting or diagnosing flavivirus infection in a sample or patient.
Patent NZ-535657-A (NZ)
Title: Process and intermediates for preparing a cyclohexylnitrile
Inventor: WEBB KEVIN SCOTT
Filed: 2001-01-12
Abstract: A method for preparing a a,b-unsaturated cyclohexene dicarbonitrile of formula (B) is disclosed, wherein the method comprises dehydrating the 1,4-dicarbonitrile cyclohexene-1-ol of formula (C), wherein Ba(OH)2 is used as a base for dehydrating the compound of formula (C) , where Ar is an aromatic group.
Patent NZ-537090-A (NZ)
Title: Medicinal compositions improving brain function and method for improving brain function
Inventor: NAKADA YASUSHI
IPC: A61K31/445
Filed: 2003-04-03
Abstract: A pharmaceutical composition for improving cerebral function is disclosed. It comprises synergistically effective amounts of the following ingredients (A) and (B). Ingredient (A) is described to be an alkyl ether derivative of the formula (I). R1 represents a substituted or unsubstituted heterocyclic group; R2 represents a hydrogen atom or a hydroxyl group; R3 and R4, which may be the same or different, each represents a substituted or unsubstituted alkyl group, or R3 and R4 taken conjointly with the nitrogen atom to which R3 and R4 are linked, form a substituted or unsubstituted cyclic amino group; m represents an integer of 1 to 5; and n represents an integer of 1 to 6. Ingredient (B) is described to be compound having an acetylcholine esterase inhibitory activity or a salt thereof, which is different from ingredient (A).